Science Explorer Back to mapMap
Discussion
Researcher · Jubilant Life Sciences (India) · India

Ravi Kanth Bhamidipati

Ravi Kanth Bhamidipati publishes mostly in Molecular Biology, Pharmacology and Analytical Chemistry, on topics such as Antibiotics Pharmacokinetics and Efficacy, Analytical Methods in Pharmaceuticals and HIV/AIDS drug development and treatment.

OpenAlex
World rank
#3,861,460
of 7,710,434 ranked researchers
Rank in India
#90,385
of 280,097
Works
34
Citations
738
Citations per work
21.7
h-index
11
i10-index 12Top 71% in Molecular Biology
Ravi Kanth Bhamidipati

What does Ravi Kanth Bhamidipati research?

Ravi Kanth Bhamidipati's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Medicine (20%), Chemistry (6%).

Everything else: 14 works · 42.5% of their workLife Sciences: 11 works · 31.5% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 27.2% of their workMolecular Biology: 9 works · 27.2% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 4.3% of their workPharmacology: 1 works · 4.3% of their workHealth Sciences: 7 works · 19.5% of their workMedicine: 7 works · 19.5% of their workPharmacology: 3 works · 9.8% of their workInfectious Diseases: 2 works · 5.4% of their workOncology: 1 works · 4.3% of their workPhysical Sciences: 2 works · 6.5% of their workChemistry: 2 works · 6.5% of their workAnalytical Chemistry: 2 works · 6.5% of their workTHEIR WORKRavi KanthBhamidipati34works
Life Sciences32%Physical Sciences6%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1442.5%
    1. Biochemistry, Genetics and Molecular Biology927.2%
    2. Pharmacology, Toxicology and Pharmaceutics14.3%
    1. Medicine719.5%
    1. Chemistry26.5%
  1. 1Molecular Biology27% of their works
  2. 2Pharmacology10% of their works
  3. 3Analytical Chemistry6% of their works
  4. 4Infectious Diseases5% of their works
  5. 5Pharmacology4% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Ravi Kanth Bhamidipati's research?

The keywords of their largest research topics: Pharmacokinetics, Antibiotic Pharmacokinetics, Critically Ill Patients, Cell Signaling, Green Analytical Chemistry, Pharmaceutical Analysis, Antiretroviral Therapy and HIV Infection.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Pharmacokinetics82 topics
  2. Antibiotic Pharmacokinetics71 topic
  3. Critically Ill Patients71 topic
  4. Cell Signaling62 topics
  5. Green Analytical Chemistry61 topic
  6. Pharmaceutical Analysis61 topic
  7. Antiretroviral Therapy51 topic
  8. HIV Infection51 topic
  9. Cytochrome P45041 topic
  10. Molecular Docking41 topic
  11. Pharmacogenetics41 topic
  12. Virtual Screening41 topic
  13. Crystal Structure31 topic
  14. Enzyme Regulation31 topic
  15. G-Protein-Coupled Receptors31 topic
  16. Ion Channels31 topic
  17. Nucleotide Metabolism31 topic
  18. Voltage-Gated Channels31 topic

Where does Ravi Kanth Bhamidipati work?

Ravi Kanth Bhamidipati's main affiliation in the publication record is Jubilant Life Sciences (India), India.

How many publications and citations does Ravi Kanth Bhamidipati have?

OpenAlex counts 34 works and 738 citations for Ravi Kanth Bhamidipati, an h-index of 11, ranking #3,861,460 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ravi Kanth Bhamidipati. Posts are plain text and can be reported.